Astellas unveils gene therapy for rare disease amid FDA commissioner turmoil
Stat News notes that Astellas has launched a new gene‑therapy treatment offering hope to patients with a previously devastating rare disease. The piece also references internal turmoil at the FDA, where questions are being raised about the possible removal of Commissioner Marty Makary.